Abstract
AbstractAccording to previous observational researches and clinical trials, the gut microbiota is related to prostate diseases. However, the potential association between gut microbiota and prostate disorders is still uncertain. We first identified groups of gut microbiota based on the phylum, class, order, family, and genus levels from consortium MiBioGen. And we acquired prostate diseases statistics from the FINNGEN study and PRACTICAL consortium. Next, two-sample Mendelian randomization was used to investigate the potential associations between three prevalent prostate disease and gut microbiota. In addition, we performed a reverse MR analysis and Benjamini-Hochberg (BH) test for further research. We investigated the connection between 196 gut microbiota and three prevalent prostate diseases. We identified 42 nominally significant associations and 2 robust causative links. Upon correction for multiple comparisons using the Benjamini–Hochberg procedure, our analysis revealed a positive correlation between the risk of prostatitis and the presence of the taxonomic order Gastranaerophilales. Conversely, the risk of prostate cancer exhibited an inverse correlation with the presence of the taxonomic class Alphaproteobacteria. Our study revealed the potential association between gut microbiota and prostate diseases. The results may be useful in providing new insights for further mechanistic and clinical studies of prostate diseases.
Funder
the National Key Research and Development Program of China
Project of Science and Technology Department of Sichuan Province
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Collins, M. M. et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J. Urol. 167(3), 1363–1366 (2002).
2. Brede, C. M. & Shoskes, D. A. The etiology and management of acute prostatitis. Nat. Rev. Urol. 8(4), 207–212 (2011).
3. Adamaki, M. & Zoumpourlis, V. Prostate cancer biomarkers: From diagnosis to prognosis and precision-guided therapeutics. Pharmacol. Ther. 228, 107932 (2021).
4. De Nunzio, C., Aronson, W., Freedland, S. J., Giovannucci, E. & Parsons, J. K. The correlation between metabolic syndrome and prostatic diseases. Eur. Urol. 61(3), 560–570 (2012).
5. Miernik, A. & Gratzke, C. Current treatment for benign prostatic hyperplasia. Dtsch. Arztebl. Int. 117(49), 843–854 (2020).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献